On January 15, 2021, Ha Tay Pharmaceutical JSC (HNX:DHT) closed the transaction. All the shares issued in the transaction were subscribed by ASKA Pharmaceutical Co., Ltd. (TSE:4514). The investor will now hold 24.9% stake in the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
47,500 VND | -0.63% | +5.56% | +106.52% |
1st Jan change | Capi. | |
---|---|---|
+106.52% | 154M | |
+50.85% | 795B | |
+41.96% | 627B | |
-7.44% | 350B | |
+18.68% | 328B | |
+8.51% | 294B | |
+18.28% | 245B | |
+1.31% | 222B | |
+11.94% | 215B | |
+3.18% | 160B |
- Stock Market
- Equities
- DHT Stock
- News Ha Tay Pharmaceutical
- Ha Tay Pharmaceutical JSC announced that it has received VND 369.70241 billion in funding from ASKA Pharmaceutical Co., Ltd.